Patients

How to Take Aztreonam Lysine for Inhalation

An electronic nebulizer developed and made by PARI Pharma GmbH, called the eFlow® Electronic Nebulizer, is being used in the aztreonam lysine for inhalation clinical trials. PARI Pharma GmbH and Gilead Sciences, Inc. worked together to design the handheld eFlow® specifically for aztreonam lysine for inhalation. The eFlow® has been used in all clinical trials for aztreonam lysine for inhalation to date. Gilead Sciences, Inc., the sponsor of this EAP, provides the eFlow® to program enrollees at no cost, along with aztreonam lysine for inhalation, for the duration of the program.

Next: Learn about eligibility criteria for this EAP